Sanofi's Sarclisa Subcutaneous Formulation Achieves Co-Primary Endpoints In IRAKLIA Phase 3 Trial For Multiple Myeloma Treatment
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Johnson & Johnson Falls After Pausing Varipulse Cases
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Patrick Rawls : nope
Ryand83 OP Patrick Rawls :